Anne Dwight R.G.N., trained as a Nurse at High Wycombe Hospital in Buckinghamshire and started a career in Accident and Emergency Nursing. Moved to Watford hospital and during this time completed a course in Developing Autonomous Practice and gained a Diploma in Specialist Nursing at Hatfield University and then practiced as an Emergency Nurse Practitioner. Worked for a couple of years inGP Practice then in a Walk in centre where she completed a Minor Illness course and Family Planning and Reproductive Sexual Health course, then moved to Mt Vernon in 2002 as an Emergency Nurse Practitioner in the Minor Injuries Department. Currently is the Manager and Matron of the M.I.U. here at Mt Vernon in a very successful and popular unit.
Adobe Flash Player not installed or older than 9.0.115!
Professor Jane Maher trained in London and Boston, USA. She has worked as an oncologist at Mount Vernon for more than 20 years. Between 1986 and 1999 she developed both oncology services for 5 hospitals in Hertfordshire, Berkshire and West London. Since 1999 she has focused on breast and prostate cancer to enable her to work across the UK with Macmillan Cancer Support as Chief Medical Officer, with NHS Improvement (Cancer) and with the DH national Cancer Survivorship initiative
In 1993 she co-founded the Lynda Jackson Macmillan centre (LJMC), which has won both an NHS Nye Bevan Award & Special Commendation from the Prime Minister ‘for the NHS Organisation that has demonstrated the most innovative ways of spreading best practice’. There are more than 60 units across the UK and in Australia based on the LJMC model.
Jane has academic appointments at University College London and at HertfordshireUniversity, established and chairs a UK Primary Care Research Collaborative involving 5 universities, has been a member of the scientific advisory committees of a wide range of grant giving bodies. She directs a research group with more than 100 peer reviewed publications and over the last 5 years she has been invited to speak or be visiting professor in Australia, Belgium, Canada,Ireland, Norway, Sweden, Belgium and India, and acted as an external advisor for the Australian Senate.
Jane’s research interests include the use of complementary and palliative treatments in cancer; long term consequences of cancer treatments and helping health professionals and patients to influence change in health organisations.
Part One
Adobe Flash Player not installed or older than 9.0.115!
Part Two
Adobe Flash Player not installed or older than 9.0.115!
Rosemary Lucey is the head of The Lynda Jackson Macmillian Centre (LJMC) for cancer support and information. It is housed in a specially designed building between the cancer centre and the chemotherapy suite near to Gate 3 and offers a support service to people affected by cancer. The centre is staffed by oncology trained health professionals and a team of trained volunteers. Services include a drop in centre and help line, counselling and complementary therapies, benefits advice, pre treatment visits and workshops. More information can be seen on their website www.ljmc.org
Rosemary's background is nursing and she has been at LJMC for 17 years, starting there as a research sister in 1993.
They do a wonderful job and have many volunteers and rely heavily on charitable donations, something well worth helping.
Adobe Flash Player not installed or older than 9.0.115!
The Accuray CyberKnife arrived at Mount Vernon Cancer Centre on Friday 28th May 2010 at 18:00 hrs. The Team from Accuray worked through to Monday Bank Holiday 18:00 hrs., to the stage you can see in this video. Now follows much work with calibration, testing, staff training etc. to ensure complete safety to the patients and staff.
This unique linear accelerator, mounted on a robotic arm, is The Accuray CyberKnife, for treating patients with cancer in various parts of the body to a high degree of accuracy and minimum discomfort not possible before. This is described precisely by Kirsti Gordon of Accuray, in a previous video.
Dates on the video are incorrect, the above are correct.
Adobe Flash Player not installed or older than 9.0.115!
Professor Gordon Rustin has been working on a trial investigating when best to treat ovarian cancer that has relapsed, since 1994. After analysing data from 1442 patients the trial run by the Medical Research Council and EORTC was selected as the number one abstract at the 2009 annual meeting of the American Society of Clinical Oncology, which is the largest cancer meeting in the world. In May 2009 Professor Rustin presented the trial results to over 15,000 people in Orlando, USA. This caused a huge debate around the world, because the results were unexpected and counterintuitive. However the message is steadily getting across that this trial provides patients with important information which will improve their quality of life.
Adobe Flash Player not installed or older than 9.0.115!
